CLINICAL_TRIALS trial_result · 2011-05-06

Clinical Trial Update: A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia [Phase 2]

Phase 2 trial evaluating the safety and tolerability of a new schizophrenia medication was completed, and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2011-05-06